Psychological distress describes a set of mental and physical symptoms such as anxiety, stress, depression, sleep disturbance and gastrointestinal upset that, at any one time, can affect up to 15% of the adult population.
The first priorities in any clinical trial conducted by our parent company, Emyria, are the patients and participants.
Our entire foundation is based around the Real-World experiences of patients, which informs how we conduct our clinical trials.
At the moment, we are working to discover the impact that Ultra-Pure CBD can have on the symptoms of psychological distress. As we now have ethics approval, we will soon begin recruitment for a Phase 3 clinical trial in multiple locations on the East Coast and in Western Australia.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat. Ut wisi enim ad minim veniam, quis nostrud exerci tation ullamcorper suscipit lobortis nisl ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip
ex ea commodo consequat.
Emerald is a team of medical doctors, clinical researchers and data scientists who work collectively with patients to provide pathways to new, evidence-based medical treatments and technologies.
